Background and objectives Living donors represented 43% of United States kidney donors in 2012. Although research suggests minimal long-term consequences of donation, few comprehensive longitudinal studies for this population have been performed. The primary aims of this study were to examine the incidence, risk factors, and causes of rehospitalization following donation.
Introduction
Living kidney donors have constituted 45% of all donors in the United States since 1988 (1) . Livingdonor transplantation is associated with a significant survival benefit compared with maintenance dialysis for patients with ESRD (2) . However, living-donor kidney transplantation has declined in the United States since 2004 despite evidence that donors with a greater prevalence of risk factors are being accepted than in past decades (3, 4) . Mortality rates are not elevated among living donors compared with the general population, even after exclusion of individuals with documented contraindications to donation; however, African Americans, Hispanics, men, and donors with hypertension have relatively increased perioperative mortality (5) . Among living donors with private health insurance, African Americans and Hispanics have an increased risk of hypertension and diabetes and an incidence of ESRD of 0.13% at a median 7.7 years of follow-up after donation (6) . The rate of selected comorbid conditions, including cancers, cardiovascular disease, depression, and fractures, following living donation is also generally similar to that among individuals characterized as the "healthiest" portion of the general population and among age-and sex-matched controls with commercial insurance (7) (8) (9) (10) .
Comprehensive follow-up information of living donors' health is unfortunately limited. Recommendations from the 2010 Living Kidney Donor Follow-Up Conference Writing Group included the need to capture information from sources beyond the Organ Procurement and Transplant Network (OPTN) and to improve surveillance of comorbid conditions (11) . To address this need, we undertook a study using data that compiled hospitalizations in the United States from the Agency for Healthcare Research and Quality (AHRQ). These data include information on every hospitalization within participating states and, as opposed to standard transplant forms, include diagnoses and procedure codes that occur within a hospitalization. Rehospitalizations following hospital admission can be a proxy for subsequent morbidity of patients, are indicators of quality of life, and are used to evaluate quality of care by health care providers (12) (13) (14) . In the United States, approximately 20% of Medicare patients are rehospitalized within 30 days after initial discharge (12, 15) . These rehospitalization rates vary by patient condition, demographic factors, region of the country, and individual facilities (16) (17) (18) . Only 10% of early rehospitalizations are considered planned, and the most common principal diagnosis class of rehospitalizations are maternal (related to childbirth and postpartum conditions) (12, 15) .
The aims of this study were to evaluate (1) the external validity of samples derived from hospitalization files for the United States living-donor population; (2) the incidence, causes, and risk factors of rehospitalizations following living donor nephrectomy; and (3) the relative risk of rehospitalizations among living donors compared with other abdominal surgical interventions.
Materials and Methods
Two data sources were used for this study. The primary data set was the State Inpatient Databases (SID), compiled by AHRQ, which contains data for the full census of hospitalizations within the respective states (19) . We used data from 2007 to 2009 for North Carolina, New York, and Florida and from 2005 to 2010 for California. These particular data were selected because more recent years contain identifiers with subsequent hospitalizations and these states were relatively large, representing diverse populations. The Scientific Registry of Transplant Recipients (SRTR) was used to compare and externally validate the composition of the sample with regard to donor characteristics in the United States over the study period. The SRTR data system includes data on all donors, wait-listed candidates, and transplant recipients in the United States, submitted by the members of OPTN, and has been described elsewhere (20) . The Health Resources and Services Administration, US Department of Health and Human Services, provides oversight to the activities of the OPTN and SRTR contractors.
Three criteria were used to identify living donors in the SID. First, patients had an International Classification of Diseases, Ninth Revision (ICD-9), diagnosis code as kidney donors (V59.4). Second, patients received an ICD-9 procedure code for nephroureterectomy (55.51). Finally, only elective admissions were included. We used SID severity files to extract information on comorbid conditions of patients. Codes for these conditions have been established by AHRQ, and algorithms are available online (21) . Comorbid conditions that were rare (,2% of the sample) or were not considered to be commonly present on admission were ignored for the purpose of this study. For comparison purposes, we also identified patients who underwent appendectomy, cholecystectomy, or nephrectomy for nonmetastatic carcinoma over the study period. We selected these conditions because they are abdominal surgeries requiring organ extraction. The codes for identifying these patients were based on prior studies using AHRQ data (22) (23) (24) . Nephrectomy for nonmetastatic carcinoma was based on a primary ICD-9 diagnosis code of 189.1 or 189.2, excluding secondary diagnoses indicating metastases of 197.0, 197.7 and 198.3, and an ICD-9 procedure code of 55.51. Appendectomies were identified on the basis of ICD-9 primary procedure codes of 47.09 or 47.01 and a primary diagnosis code of 541.3, 542.3, 540.0, 540.1, or 540.9. Cholecystectomies were identified by ICD-9 diagnoses codes of 574.3, 575.3, or 576.3 and a primary ICD-9 diagnosis code of 51.22 or 51.23.
To evaluate rehospitalization rates, we used the linking variable (visit link) provided in the SID. A limitation of these data is an inability to track patients across different states. As such, we limited the study population to patients who donated in the same state as their primary residence to minimize likelihood of hospitalizations not captured in other states. Kaplan-Meier plots and cumulative incidence curves were generated for time to rehospitalization following initial discharge. We used Cox proportional hazard models to evaluate independent risk factors for time to rehospitalization. Rehospitalizations were considered "all- cause"; however, we also generated models censoring followup at hospitalizations for pregnancy-related complications because the latter association was not related to morbidity. The inception time for survival models was the month of the index hospitalization (because exact dates are not provided), and models were censored in December of the last year of data available. We used an adjustment (robust sandwich estimator) for clustering of patients within hospitals in all Cox models. The clinical and research activities being reported are consistent with the Principles of the Declaration of Istanbul, as outlined in the "Declaration of Istanbul on Organ Trafficking and Transplant Tourism."
The study was approved by the Cleveland Clinic Institutional Review Board. All analyses were conducted using SAS software, version9.2 (SAS Institute, Inc., Cary, NC).
Results

Study Population
The number of living donors initially identified in the SID was 5601. Four percent of individuals received a diagnosis of living donation but did not have an applicable procedure code or the procedure was not labeled as elective. In addition, 1077 patients were excluded because of residence in a state other than that for the hospital where the transplant was performed. Donors from out of state compared with those in the same state were slightly older (43 versus 41 years; P,0.001), more often white (76% versus 62%; P,0.001), and more likely to be male (43% versus 39%; P=0.01). Demographic characteristics of the remaining study population (n=4524) were relatively similar to those of all living donors between 2005 and 2010 in the SRTR (n=39,364) ( Table 1 ). The principal exception was a higher prevalence of donors classified as Hispanic (21.2%) in the SID than in the SRTR (13.4%).
Rehospitalizations among Living Donors
The cumulative 1-and 3-year incidences of all-cause rehospitalizations among living donors were 5% and 11%, respectively; for non-pregnancy-related hospitalizations, the rates were 5% and 9%. The incidence of rehospitalization was higher among women (only for all-cause rehospitalizations), African Americans and Hispanics, patients with diagnoses of depression and hypothyroidism, variation by insurance status and state of residence, and patients who had a longer length of stay during their initial hospitalization ( Table 2 ). Time to rehospitalization (censored at rehospitalization for pregnancy-related diagnoses) are displayed in Figure 1 , A-D, by age, race, depression, and hypothyroidism, which were all associated with significant differences. On the basis of the multivariable model, older age, hypothyroidism, African Americans, length of stay .4 days, and depression were all independently associated with higher risks for rehospitalization (Table 3) .
Primary Diagnoses at Rehospitalization among Living Donors
A total of 456 living donors required rehospitalization. The most common class of diagnoses codes was pregnancyrelated causes (21%). Other diagnosis classes in descending order were diseases of the digestive system (14%), injuries and poisoning (13%), diseases of the genitourinary system (8%), mental disorders (6%), diseases of the musculoskeletal system (5%), neoplasms (5%), and diseases of the circulatory system (4%). Other than pregnancy-related causes, primary diagnoses did not differ by sex. Pregnancy-related diagnoses were most common among Hispanics (34%; P=0.002), and mental disorders most common among whites (8%; P=0.001). Older donors (age.59 years) were more likely to be rehospitalized with diseases of the musculoskeletal system (12%; P=0.001) and neoplasms (15%; P,0.001) compared with younger donors. Only 0.2% of rehospitalizations were classified as caused by complications related to pregnancy, including pre-eclampsia.
Rehospitalization Rates between Different Surgical Interventions
Characteristics of living donors compared with those of patients undergoing other abdominal surgical interventions are displayed in Table 4 . Living donors more often were female and white and had Medicare as the primary payer than patients undergoing appendectomy or cholecystectomy. Patients undergoing nephrectomy for nonmetastatic carcinoma were generally older, male, and white. Diagnoses of depression, obesity, hypertension, hypothyroidism, and chronic pulmonary disorder were generally lower among living donors than among other groups. Overall, 21% of the study population had a rehospitalization over the study period, with median follow-up of 731 days (25th percentile, 365 days; 75th percentile, 1126 days) and maximum follow-up of 2160 days (5.9 years). The median (25th percentile, 75th percentile) lengths of stay during rehospitalization were 2 (1,4) days for living donors, 3 (2,6) days for nephrectomy for carcinoma, 3 (2,5) days for appendectomy, and 3 (2,6) days for cholecystectomy. The overall rates of all rehospitalizations (including multiple events for individuals) were as follows: living donor nephrectomy, 1.43/10,000 patient-years; nephrectomy for carcinoma, 15.15/10,000 patient-years; appendectomy, 3.00/10,000 patient-years; and cholecystectomy, 8.41/10,000 patient-years. Compared with other surgery groups, with censoring of pregnancyrelated hospitalizations, living donors had a significantly longer time to initial rehospitalization ( Figure 2 ). Differences were consistent in the multivariable model adjusting for patient characteristics at the time of initial hospitalization. Compared with living donors, adjusted risks for rehospitalizations were greater among patients undergoing appendectomy (adjusted hazard ratio [AHR], 1.58; 95% confidence interval [95% CI], 1.42 to 1.75), cholecystectomy (AHR, 2.25; 95% CI, 2.03 to 2.50), and nephrectomy for nonmetastatic carcinoma (AHR, 2.95; 95% CI, 2.58 to 3.37).
Risk factors for rehospitalization were relatively similar between surgical groups. The relative risk for rehospitalizations was higher for African Americans than whites in each surgical group. However, the relative odds were numerically lower in the comparison groups: appendectomy (AOR, 1.38; 95% CI, 1.31 to 1.45), cholecystectomy (AOR, 1.16; 95% CI, 1.13 to 1.19), and nephrectomy for nonmetastatic carcinoma (AOR, 1.36; 95% CI, 0.91 to 1.36). Older age and diagnosis of depression were consistent risk factors in each surgical group, while hypothyroidism had a numerically higher risk among living donors. Among women aged 18-40 years, the proportions of rehospitalizations due to pregnancyrelated causes were 50% among living donors, 51% among patients having appendectomy, 41% among patients having cholecystectomy, and ,1% among patients having nephrectomy for carcinoma. Rehospitalizations related to pregnancyrelated complications among women aged 18-40 were slightly higher among patients initially hospitalized for appendectomy (0.4%) and cholecystectomy (0.5%) than among living donors (0.2%).
Discussion
The primary findings of the study were that (1) the SID provides a valuable source for analysis of outcomes and characteristics of living donors in the United States and, on the basis of these data, (2) the 3-year rehospitalization rate among living donors is 11%, (3) non-pregnancy-related rehospitalizations among living donors are higher for African Americans, older patients, patients with longer initial length of stay, and patients with documented diagnoses of depression and hypothyroidism, (4) rehospitalizations among living donors are significantly lower than among patients undergoing appendectomy, cholecystectomy, and nephrectomy for nonmetastatic carcinoma, and (5) certain risk factors for rehospitalizations, including African American race and depression, are not unique to living donation and are consistently higher in each of the surgical groups evaluated in this study. Cumulatively, these data confirm that long-term morbidity associated with living donation is relatively modest but significantly varies within the donor population.
Comprehensive long-term assessment of living-donor health has been challenging in the United States, partially because of incomplete documentation of donor status on standard follow-up forms (25, 26) . The AHRQ files used in this study provide a unique opportunity to evaluate living-donor outcomes for several reasons. These data have specific information about patients and processes of care, including all diagnosis and procedure codes that occur during hospitalization. This information is distinct from United Network for Organ Sharing forms, which do not assess a variety of comorbid conditions, and is also distinct from single-payer data (e.g., Medicare) because patients with different payer status may have unique conditions and outcomes. As presented in this study, these data also are not limited to transplant events and as such can be compared with other conditions necessitating hospitalizations. Importantly, the data appeared to have high external validity for identifying living donors given the similarity with national registry data over the contemporaneous period.
One of the aims of the study was to evaluate the incidence of rehospitalizations compared with other surgical conditions. Other studies have documented differences between living-donor outcomes and the general population; these studies include important findings but have certain limitations (5) (6) (7) . Given that donors are carefully screened for physical and mental conditions and likely have intrinsic differences from the general population, including voluntary acceptance of a major surgical intervention, living donors might be expected to have more favorable outcomes. However, it is equally important to appreciate that living donors are also likely to be systematically different from the comparison groups used in this study. Despite the similarity of abdominal surgery that includes organ extraction, the more emergent nature of the conditions used for comparison in this study may also represent greater acuity among these patients and subsequent likelihood for rehospitalization. Given that an ideal control group (such as patients who were evaluated and considered viable for donation but did not ultimately donate) is difficult to identify in large numbers, it is important to place all research concerning the health of living donors in perspective and consider the relative strengths and weaknesses of each approach. An interesting finding of the study was that risk factors for rehospitalization among living donors, including African American race and depression, were also evident in other surgical groups. This may suggest that patients with these characteristics are more likely to require hospitalization in general, irrespective of patients' initial requirement for hospitalization, and as such may not be unique to living donation. In other words, for these characteristics, we might expect to observe higher rehospitalization rates independent of a patient undergoing donor nephrectomy (and thus these rates are not a direct consequence of the procedure). However, it also should be noted that numerically the relative risks for rehospitalizations for African Americans and patients with hypothyroidism were highest among living donors compared with other surgical groups.
A primary focus of this study was to evaluate the relative risks for rehospitalizations within the living-donor population. Ibrahim et al. previously reported that women were relatively more likely to have reduced renal function but less likely to have albuminuria following living donation (27) . In the current study, women had increased rehospitalization rates; however, the increase was largely explained by pregnancy-related hospitalizations and as such does not appear to indicate excess morbidity. Also of note, among women of child-bearing age, the rate of pregnancy-related rehospitalizations among donors was similar to that among patients undergoing appendectomy and cholecystectomy, and among donors there was a very (28) . Although the overall rate of rehospitalizations among donors is low, the relatively increased rates among African Americans are still noteworthy. Differences in short-and long-term outcomes among these groups relative to those in whites have been documented in other studies and merit continued surveillance (5, 6) . The primary diagnoses at rehospitalization were not markedly different by race/ethnicity except for higher rates for pregnancy-related hospitalizations among Hispanics and higher rates of hospitalizations for mental disorders among whites. As such, there does not appear to be a specific notable cause for this increased rate among African-Americans, but it should also be placed in context with the prior discussion that these elevated risks are not unique to living donors. Another notable outcome of the study was an 80% elevated adjusted risk of rehospitalization among donors with diagnoses of depression. Although only 2% of donors had documented diagnoses of depression, findings suggest that baseline and ongoing monitoring for depression are particularly important in this population. Lentine et al. reported that the incidence of depression among privately insured living donors was 11% at 5 years, reaffirming that this is a common and potential severe condition leading to hospitalization (9) . Perhaps not surprisingly, donors with longer length of initial stay had increased risk of rehospitalization. This may indicate more complicated surgeries or perioperative complications that are more likely to manifest following initial discharge and may indicate that these donors require more vigilant follow-up care.
As described previously, using AHRQ data for research in the living-donor population has several advantages. However, there are also limitations that are important to consider. Because these data are used for administrative purposes, documentation of certain diagnoses and outcomes may not be complete, particularly for diagnoses not used for billing purposes. For example, obesity was diagnosed infrequently (2%) relative to the known proportion of actual obese living donors; as such, some caution with extrapolating certain results of this study is warranted (29) . These data also do not include deaths that occur outside of hospitalizations, such that the estimated incidence of rehospitalizations is likely higher than reported based on some patient deaths rendering them no longer at risk for rehospitalization over time. In addition, rehospitalizations were limited to those within the same state, which likely resulted in an undercount of rehospitalizations. It is possible this may have affected some of the relative comparisons.
In summary, this study has several principal findings. First, the rehospitalization rate 3 years following living donation is approximately 11%. The incidence of rehospitalization is substantially less than that in patients undergoing other common abdominal surgeries. Excluding pregnancy-related hospitalizations, there is a relative increased risk for rehospitalization among African Americans, older donors, and patients diagnosed with depression and hypothyroidism. Further efforts to critically evaluate the long-term health of the living-donor population from all available data sources are needed.
